BackOrthocell Limited Overview

Orthocell Limited Intangible Assets

Track Orthocell Limited's intangible assets ($770K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$773207.00
↓ 27.89% YoYΔ $-299063.00 vs prior year quarter

Peer trimmed avg / median

Loading

Orthocell Limited Intangible Assets History

Loading

Orthocell Limited vs. peers: Intangible Assets Comparison

Loading

Orthocell Limited Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orthocell Limited (OCC.AX) FAQ

Orthocell Limited's intangible assets stands at $770K as of June 2026. That compares with $1.1M in the prior-year period — down 27.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Orthocell Limited reported $770K in intangible assets versus $1.1M a year earlier — a 27.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.1M in the prior-year period — down 27.9% year over year. Sustained growth in intangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Orthocell Limited's intangible assets evolved across reporting periods, while the comparison chart places OCC.AX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, intangible assets is commonly used to spot outliers. Orthocell Limited's reading of $770K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.